DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Soulen MC, van Houten D, Teitelbaum UR, Damjanov N, Cengel KA, Metz DC.
Safety and feasibility of integrating yttrium-90 radioembolization with capecitabine-temozolomide for grade 2 liver-dominant metastatic neuroendocrine tumors.
Pancreas 2018;
47 (08) 980-984
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.